Canada Allows Import of J&J COVID-19 Vaccine Doses Made at Emergent Facility

The Canadian health regulator said on Wednesday it would allow Johnson & Johnson to import its COVID-19 vaccine made at contract manufacturer Emergent BioSolutions Inc’s plant in Baltimore, Maryland. Read More